In addition, FBP is strongly correlated with c-Myc expression, and knocking down FBP1 expression could suppress NPC progression in vitro and in vivo, which suggested that FBP1 could be a potential therapeutic target in reducing chemoresistance and radioresistance as well as reducing tumor progression in NPC. This evidence concerns the gene FBP1 and nasopharyngeal carcinoma.